Anticoagulation assessment in ventricular assist device (VAD) patients скачать в хорошем качестве

Anticoagulation assessment in ventricular assist device (VAD) patients

For more detail: http://www.annalscts.com/article/view... Bleeding and thromboembolism are serious adverse events that have been associated with the use of ventricular assist devices (VADs). Historically, anti-thrombotic therapy was recommended in treatment protocols and included the early postoperative use of intravenous heparin as a transition to warfarin and aspirin therapy. Hence, anticoagulation therapy is in itself an additional risk factor for the onset of hematological complications.This video looks at determining the optimal anticoagulation for individual patients. Video Chapters 00:00:28 Introduction 00:08:53 Flow stagnation and Patient condition 00:13:25 Patient-device interaction 00:16:24 Pump design 00:22:09 DHZB Protocol 00:34:21 Anticoagulation schemes 00:53:59 Weaning procedure 00:65:43 Conclusion Cite this article as: Stepanenko A, Potapov EV, Weng Y, Pasic M, Krabatsch T, Hetzer R. Anticoagulation assessment. Ann Cardiothorac Surg 2014;3(5):538-540. doi: 10.3978/j.issn.2225-319X.2014.08.07 The Annals of Cardiothoracic Surgery (ACS) is a bi-monthly peer-reviewed scientific journal, focusing on the latest clinical evidence and surgical techniques. For more information regarding upcoming issues and manuscript submissions please visit: www.annalscts.com.